Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 30, 2017 - Issue 2
Submit an article Journal homepage
225
Views
5
CrossRef citations to date
0
Altmetric
Case Studies

Leukocytoclastic Vasculitis Drug Reaction to Certolizumab Pegol

Meghan WoodyCorrespondence[email protected]
, MD, MPH,
Donald Warren
, MD,
Laura Speck
, MD &
Julie Jackson
, MD
Pages 213-214 | Published online: 11 Dec 2017

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ciro Romano, Sergio Esposito, Roberta Ferrara & Giovanna Cuomo. (2021) Tailoring biologic therapy for real-world rheumatoid arthritis patients. Expert Opinion on Biological Therapy 21:5, pages 661-674.
Read now

Articles from other publishers (4)

Camila da Silva Cendon Duran, Adriane Souza da Paz & Mittermayer Barreto Santiago. (2022) Vasculitis induced by biological agents used in rheumatology practice: A systematic review. Archives of Rheumatology 37:2, pages 300-310.
Crossref
Ecem Bostan, Duygu Gulseren, Basak Yalici‐Armagan, Sibel Dogan, Deniz Ates‐Ozdemir, Ozay Gokoz, Umut Kalyoncu & Nilgün Atakan. (2021) Vasculitis during certolizumab pegol and secukinumab treatment: Report of two cases. Dermatologic Therapy 34:4.
Crossref
Meredith Buck, Igor Dumic, Wendy McDermott, Charles Nordstrom, Samarth Dawan, Andrew Virata, Scott Martin, Ann Hudson, Tamara Milovanovic & Terri Nordin. (2020) Leukocytoclastic vasculitis as a rare dermatologic manifestation of Crohn’s disease mimicking cellulitis: a case report. BMC Gastroenterology 20:1.
Crossref
Yoshiro Horai, Hiroshi Ishikawa, Nozomi Iwanaga, Yasumori Izumi, Yuki Matsuoka, Shiro Miura & Atsushi Kawakami. (2020) Development of hypocomplementemic urticarial vasculitis during certolizumab pegol treatment for rheumatoid arthritis: A case report. Journal of Clinical Pharmacy and Therapeutics 45:5, pages 1179-1182.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.